State agencies and lawmakers in Indiana are proceeding with a plan that could use revenue generated by raising Indiana Toll Road rates to help with infrastructure projects, including the state’s share ...

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET Samir Kapadia, Managing Principal at Vogel Group, says the first issue that needs to be addressed on the Strait of Hormuz is whether Iran can ...

Microsoft Corp. aims to develop large, cutting-edge artificial intelligence models by next year, part of a push to build in-house alternatives to the most powerful AI tools from OpenAI and Anthropic. ...

OpenAI said the deal would help it “create a space for a real, constructive conversation about the changes A.I. creates.” By Mike Isaac Mike Isaac covers artificial intelligence and wrote about the ...

A victory for President Donald Trump in the birthright citizenship case before the Supreme Court would not only create a mountain of paperwork for many Americans, but could also create a class of ...

CHARLESTON, S.C. (WCSC) — AVM Group, a national provider of turnkey controlled environments, will establish its national headquarters in Charleston County, the company announced. The $5 million ...

Anthropic's Claude chatbot has been updated with support for inline visual content that will help it provide clearer answers. Claude can now create custom visuals like charts, graphs, and diagrams.

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

On Tuesday, OpenAI introduced dynamic visual explanations, a new ChatGPT feature that allows users to see how formulas, variables, and mathematical relationships change in real time. Instead of just ...

Lest you thought Microsoft would have all the fun introducing new AI features for white collar enterprise work this week with its Copilot Cowork announcement yesterday, Google is here to take back the ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...